Oliver Holger Krämer (Oliver H Krämer, Al-Hassan M Mustafa)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 30

Top Topics

Cell Cycle Arrest

Reactive Oxygen Species

Top Venues

Molecular oncology

Pharmacological reviews

Archives of toxicology

This page only lists publications with an associated author ORCID identifier.

Publications

Anita G Kansy, Ramy Ashry, Al-Hassan M Mustafa, Abdallah M Alfayomy, Markus P Radsak, Yanira Zeyn, Matthias Bros, Wolfgang Sippl, Oliver Holger Krämer
Pharmacological degradation of ATR induces antiproliferative DNA replication stress in leukemic cells. Molecular oncology 18 (8) (2024)
Anita G Kansy, Ramy Ashry, Al-Hassan M Mustafa, Abdallah M Alfayomy, Markus P Radsak, Yanira Zeyn, Matthias Bros, Wolfgang Sippl, Oliver Holger Krämer
Pharmacological degradation of ATR induces antiproliferative DNA replication stress in leukemic cells. Molecular oncology 18 (8) (2024)
Melisa Halilovic, Mohamed Abdelsalam, Joanna Zabkiewicz, Michelle Lazenby, Caroline L Alvares, Matthias Schmidt, Walburgis Brenner, Sara Najafi, Ina Oehme, Christoph Hieber, Yanira Zeyn, Matthias Bros, Wolfgang Sippl, Oliver Holger Krämer
Selective degradation of mutant FMS-like tyrosine kinase-3 requires BIM-dependent depletion of heat shock proteins. Leukemia (2024)
Anita G Kansy, Ramy Ashry, Al-Hassan M Mustafa, Abdallah M Alfayomy, Markus P Radsak, Yanira Zeyn, Matthias Bros, Wolfgang Sippl, Oliver Holger Krämer
Pharmacological degradation of ATR induces antiproliferative DNA replication stress in leukemic cells. Molecular oncology (2024)
Anita G Kansy, Ramy Ashry, Al-Hassan M Mustafa, Abdallah M Alfayomy, Markus P Radsak, Yanira Zeyn, Matthias Bros, Wolfgang Sippl, Oliver Holger Krämer
Pharmacological degradation of ATR induces antiproliferative DNA replication stress in leukemic cells. Molecular oncology 18 (8) (2024)
Matthias Wirth, Walburgis Brenner, Oliver Holger Krämer
Boosting T cell immunity against cytomegalovirus: a potential strategy combating human aging and age-related diseases. Signal transduction and targeted therapy 8 (1) (2023)
Yanira Zeyn, Kristin Hausmann, Melisa Halilovic, Mandy Beyer, Hany S Ibrahim, Walburgis Brenner, Siavosh Mahboobi, Matthias Bros, Wolfgang Sippl, Oliver Holger Krämer
Histone deacetylase inhibitors modulate hormesis in leukemic cells with mutant FMS-like tyrosine kinase-3. Leukemia (2023)
Diaaeldin I Abdallah, Elvin Dominic de Araujo, Naman H Patel, Lina S Hasan, Richard H Moriggl, Oliver Holger Krämer, Patrick Thomas Gunning
Medicinal chemistry advances in targeting class I histone deacetylases. Exploration of targeted anti-tumor therapy 4 (4) (2023)
Ramy Ashry, Al-Hassan M Mustafa, Kristin Hausmann, Michael Linnebacher, Susanne Strand, Wolfgang Sippl, Matthias Wirth, Oliver Holger Krämer
NOXA Accentuates Apoptosis Induction by a Novel Histone Deacetylase Inhibitor. Cancers 15 (14) (2023)
Désirée Gül, Oliver Holger Krämer, Christoph Reinhardt
Starving out brain tumors: a reprogrammed lysine catabolism serves as a novel target for glioblastoma treatment. Signal transduction and targeted therapy 8 (1) (2023)
Christian Marx, Jürgen Sonnemann, Oliver D K Maddocks, Lisa Marx-Blümel, Mandy Beyer, Doerte Hoelzer, René Thierbach, Claudia Maletzki, Michael Linnebacher, Thorsten Heinzel, Oliver Holger Krämer
Global metabolic alterations in colorectal cancer cells during irinotecan-induced DNA replication stress. Cancer & metabolism 10 (1) (2022)
Oliver Holger Krämer, Ramy Ashry, Al-Hassan M Mustafa
Monitoring Changes in Intracellular Reactive Oxygen Species Levels in Response to Histone Deacetylase Inhibitors. Methods in molecular biology (Clifton, N.J.) 2589 (2022)
Lukas Krauß, Bettina C Urban, Sieglinde Hastreiter, Carolin Schneider, Patrick Wenzel, Zonera Hassan, Matthias Wirth, Katharina Lankes, Andrea Terrasi, Christine Klement, Filippo M Cernilogar, Rupert Öllinger, Niklas de Andrade Krätzig, Thomas Engleitner, Roland M Schmid, Katja Steiger, Roland Rad, Oliver Holger Krämer, Maximilian Reichert, Gunnar Schotta, Dieter Saur, Günter Schneider
HDAC2 Facilitates Pancreatic Cancer Metastasis. Cancer research 82 (4) (2022)
Lili Lu, Randy Przybylla, Yuru Shang, Meng Dai, Mathias Krohn, Oliver Holger Krämer, Christina Susanne Mullins, Michael Linnebacher
Microsatellite Status and IκBα Expression Levels Predict Sensitivity to Pharmaceutical Curcumin in Colorectal Cancer Cells. Cancers 14 (4) (2022)
Al-Hassan M Mustafa, Oliver Holger Krämer
Pharmacological Modulation of the Crosstalk between Aberrant Janus Kinase Signaling and Epigenetic Modifiers of the Histone Deacetylase Family to Treat Cancer. Pharmacological reviews 75 (1) (2022)
Al-Hassan M Mustafa, Oliver Holger Krämer
Pharmacological Modulation of the Crosstalk between Aberrant Janus Kinase Signaling and Epigenetic Modifiers of the Histone Deacetylase Family to Treat Cancer. Pharmacological reviews 75 (1) (2022)
Andreas O Mieland, Mandy Beyer, Oliver Holger Krämer
News and views : AUTOTACs join the arena for targeted protein degradation. Archives of toxicology 96 (7) (2022)
Al-Hassan M Mustafa, Oliver Holger Krämer
Pharmacological Modulation of the Crosstalk between Aberrant Janus Kinase Signaling and Epigenetic Modifiers of the Histone Deacetylase Family to Treat Cancer. Pharmacological reviews 75 (1) (2022)
Oliver Holger Krämer, Günter Schneider
Single-cell profiling guided combination therapy of c-Fos and histone deacetylase inhibitors in diffuse large B-cell lymphoma. Clinical and translational medicine 12 (5) (2022)
Nicole Kiweler, Helena Schwarz, Alexandra Nguyen, Stephanie Matschos, Christina Mullins, Andrea Piée-Staffa, Christina Brachetti, Wynand P Roos, Günter Schneider, Michael Linnebacher, Walburgis Brenner, Oliver Holger Krämer
The epigenetic modifier HDAC2 and the checkpoint kinase ATM determine the responses of microsatellite instable colorectal cancer cells to 5-fluorouracil. Cell biology and toxicology (2022)
René Winkler, Ann-Sophie Mägdefrau, Eva-Maria Piskor, Markus Kleemann, Mandy Beyer, Kevin Linke, Lisa Hansen, Anna-Maria Schaffer, Marina E Hoffmann, Simon Poepsel, Florian Heyd, Petra Beli, Tarik Möröy, Siavosh Mahboobi, Oliver Holger Krämer, Christian Kosan
Targeting the MYC interaction network in B-cell lymphoma via histone deacetylase 6 inhibition. Oncogene 41 (40) (2022)
Al-Hassan M Mustafa, Oliver Holger Krämer
Pharmacological Modulation of the Crosstalk between Aberrant Janus Kinase Signaling and Epigenetic Modifiers of the Histone Deacetylase Family to Treat Cancer. Pharmacological reviews 75 (1) (2022)
Al-Hassan M Mustafa, Oliver Holger Krämer
Novel insight into mechanisms for ATR activation by chromatin structures. Archives of toxicology 95 (10) (2021)
Vanessa Wachholz, Al-Hassan M Mustafa, Yanira Zeyn, Sven J Henninger, Mandy Beyer, Melanie Dzulko, Andrea Piée-Staffa, Christina Brachetti, Patricia S Haehnel, Andreas Sellmer, Siavosh Mahboobi, Thomas Kindler, Walburgis Brenner, Teodora Nikolova, Oliver Holger Krämer
Inhibitors of class I HDACs and of FLT3 combine synergistically against leukemia cells with mutant FLT3. Archives of toxicology (2021)
Alexandra Nguyen, Melanie Dzulko, Janine Murr, Yun Yen, Günter Schneider, Oliver Holger Krämer
Class 1 Histone Deacetylases and Ataxia-Telangiectasia Mutated Kinase Control the Survival of Murine Pancreatic Cancer Cells upon dNTP Depletion. Cells 10 (10) (2021)
Hany S Ibrahim, Mohamed Abdelsalam, Yanira Zeyn, Matthes Zessin, Al-Hassan M Mustafa, Marten A Fischer, Patrik Zeyen, Ping Sun, Emre F Bülbül, Anita Vecchio, Frank Erdmann, Matthias Schmidt, Dina Robaa, Cyril Barinka, Christophe Romier, Mike Schutkowski, Oliver Holger Krämer, Wolfgang Sippl
Synthesis, Molecular Docking and Biological Characterization of Pyrazine Linked 2-Aminobenzamides as New Class I Selective Histone Deacetylase (HDAC) Inhibitors with Anti-Leukemic Activity. International journal of molecular sciences 23 (1) (2021)
Christian Marx, Jürgen Sonnemann, Mandy Beyer, Oliver D K Maddocks, Sergio Lilla, Irene Hauzenberger, Andrea Piée-Staffa, Kanstantsin Siniuk, Suneetha Nunna, Lisa Marx-Blümel, Martin Westermann, Tobias Wagner, Felix B Meyer, René Thierbach, Christina S Mullins, Said Kdimati, Michael Linnebacher, Francesco Neri, Thorsten Heinzel, Zhao-Qi Wang, Oliver Holger Krämer
Mechanistic insights into p53-regulated cytotoxicity of combined entinostat and irinotecan against colorectal cancer cells. Molecular oncology 15 (12) (2021)
Miriam Pons, Yanira Zeyn, Stella Zahn, Nisintha Mahendrarajah, Brent D G Page, Patrick T Gunning, Richard H Moriggl, Walburgis Brenner, Falk Butter, Oliver Holger Krämer
Oncogenic Kinase Cascades Induce Molecular Mechanisms That Protect Leukemic Cell Models from Lethal Effects of De Novo dNTP Synthesis Inhibition. Cancers 13 (14) (2021)
Benjamin Franz Schmalohr, Al-Hassan M Mustafa, Oliver Holger Krämer, Diana Imhof
Structural Insights into the Interaction of Heme with Protein Tyrosine Kinase JAK2*. Chembiochem : a European journal of chemical biology 22 (5) (2020)
Nicole Kiweler, Désirée Wünsch, Matthias Wirth, Nisintha Mahendrarajah, Günter Schneider, Roland H Stauber, Walburgis Brenner, Falk Butter, Oliver Holger Krämer
Histone deacetylase inhibitors dysregulate DNA repair proteins and antagonize metastasis-associated processes. Journal of cancer research and clinical oncology 146 (2) (2020)